Positive Phase 2 Trial Results Drive Viking Therapeutics (VKTX) Stock Upwards

TipRanks18:16

Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?

Yahoo FinanceNov 23 00:31

How Is The Market Feeling About Viking Therapeutics?

BenzingaNov 23 00:15

Viking Therapeutics Analyst Ratings

BenzingaNov 22 21:24 · Ratings

B.Riley Financial Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $109

Futu NewsNov 22 09:32 · Ratings

Viking Therapeutics: Strong Potential in Obesity and Type 2 Diabetes Market With Innovative VK2735 Program

TipRanksNov 22 09:15